SSPL Securities Private Limited

Monday 11 Aug, 2025 05:28 PM

Patel Engg jumps after Q1 PAT climbs 56% YoY to Rs 75 cr JM Financial Q1 PAT soars 166% YoY to Rs 454 cr Dee Development sizzles after reporting multi-fold jump in Q1 PAT DOMS Inds spurts after Q1 PAT jumps 10.5% YoY to Rs 57 cr Voltas slumps as Q1 PAT slides 58% YoY to Rs 140 cr PG Electroplast Ltd leads losers in 'A' group Dr Reddy's Lab receives EIR from USFDA for Telangana API facility Sharika Enterprises Ltd leads losers in 'B' group Ipca Labs Q1 PAT climbs 21% YoY to Rs 233 cr Volumes spurt at Doms Industries Ltd counter L&T edges higher after bagging 'ultra-mega' thermal power project from Adani Power Ceigall India slips after Q1 PAT slides 33% YoY to Rs 53 cr Shipping Corp Q1 PAT jumps 21% YoY to Rs 354 cr Mankind Pharma Ltd slips for fifth straight session NLC India Ltd down for fifth straight session

Saravan Stocks

Hot Pursuit

Scrips, which has significant changes during the market hours.

Ipca Labs Q1 PAT climbs 21% YoY to Rs 233 cr

11-Aug-25 14:36 Hrs IST

Revenue from operations jumped 10.33% year on year to Rs 2,308.85 crore in the quarter ended 30 June 2025.

Profit before tax (PBT) increased 13.81% to Rs 330.51 crore in Q1 FY25, compared with Rs 290.39 crore in Q1 FY25.

EBITDA stood at Rs 424.58 crore in Q1 FY26, registering the growth of 10%, compared with Rs 387.49 crore in Q1 FY25. Consolidated EBITDA margin (before forex (gain)/loss, other income and exceptional items) stood at 18.39% in Q1 FY26 as against at 18.52% in Q1 FY25.

During the quarter, total formulations were at Rs 1,410.62 crore, up 11% YoY. Domestic business stood at Rs 961.01 crore (up 10% YoY).

Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.

Shares of Ipca Laboratories fell 3.62% to Rs 1,334.40 on the BSE.

Powered by Capital Market - Live News

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 43376823

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)